These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Clinical and functional implication of the components of somatostatin system in gastroenteropancreatic neuroendocrine tumors. Herrera-Martínez AD; Gahete MD; Pedraza-Arevalo S; Sánchez-Sánchez R; Ortega-Salas R; Serrano-Blanch R; Luque RM; Gálvez-Moreno MA; Castaño JP Endocrine; 2018 Feb; 59(2):426-437. PubMed ID: 29196939 [TBL] [Abstract][Full Text] [Related]
23. [Small bowel neuroendocrine tumours: to be considered in the differential diagnosis of unexplained abdominal pain and diarrhoea]. Franssen GJH; van Ginhoven TM; Hofland J; Feelders RA; Geilvoet W; van Lanschot JB Ned Tijdschr Geneeskd; 2020 Jan; 164():. PubMed ID: 32186828 [TBL] [Abstract][Full Text] [Related]
24. Neuroendocrine Tumors and Lanreotide Depot: Clinical Considerations and Nurse and Patient Preferences. Ryan P; Phan AT; Adelman DT; Iwasaki M Clin J Oncol Nurs; 2016 Dec; 20(6):E139-E146. PubMed ID: 27857269 [TBL] [Abstract][Full Text] [Related]
25. [The diagnostic value of plasma chromogranin A in neuroendocrine tumors]. Yang XO; Li JN; Qian JM; Yang H; Chen Q; Lu L Zhonghua Nei Ke Za Zhi; 2011 Feb; 50(2):124-7. PubMed ID: 21418832 [TBL] [Abstract][Full Text] [Related]
26. Supportive therapy in gastroenteropancreatic neuroendocrine tumors: Often forgotten but important. Jin XF; Spampatti MP; Spitzweg C; Auernhammer CJ Rev Endocr Metab Disord; 2018 Jun; 19(2):145-158. PubMed ID: 29464446 [TBL] [Abstract][Full Text] [Related]
27. Consideration of quality of life in the treatment decision-making for patients with advanced gastroenteropancreatic neuroendocrine tumors. Naraev BG; Mailman J; Halfdanarson TR; Soares HP; Mittra ES; Hallet J Expert Rev Anticancer Ther; 2023 Jun; 23(6):601-615. PubMed ID: 37158050 [TBL] [Abstract][Full Text] [Related]
28. Somatostatin analogue-induced pancreatic exocrine insufficiency in patients with neuroendocrine tumors: results of a prospective observational study. Lamarca A; McCallum L; Nuttall C; Barriuso J; Backen A; Frizziero M; Leon R; Mansoor W; McNamara MG; Hubner RA; Valle JW Expert Rev Gastroenterol Hepatol; 2018 Jul; 12(7):723-731. PubMed ID: 29923433 [TBL] [Abstract][Full Text] [Related]
29. Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study. Halperin DM; Shen C; Dasari A; Xu Y; Chu Y; Zhou S; Shih YT; Yao JC Lancet Oncol; 2017 Apr; 18(4):525-534. PubMed ID: 28238592 [TBL] [Abstract][Full Text] [Related]
30. Advances and Current Concepts in the Medical Management of Gastroenteropancreatic Neuroendocrine Neoplasms. Alexandraki KI; Karapanagioti A; Karoumpalis I; Boutzios G; Kaltsas GA Biomed Res Int; 2017; 2017():9856140. PubMed ID: 29349087 [TBL] [Abstract][Full Text] [Related]
31. Epidemiological features of gastroenteropancreatic neuroendocrine tumors in Chengdu city with a population of 14 million based on data from a single institution. Guo LJ; Wang CH; Tang CW Asia Pac J Clin Oncol; 2016 Sep; 12(3):284-8. PubMed ID: 27170574 [TBL] [Abstract][Full Text] [Related]
32. [The state of the art of imaging in gastroenteropancreatic neuroendocrine tumors]. Yao X; Wang F Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 Jan; 45(1):51-5. PubMed ID: 27045241 [TBL] [Abstract][Full Text] [Related]
33. Epidemiology, clinical features and diagnosis of gastroenteropancreatic endocrine tumours. Tomassetti P; Migliori M; Lalli S; Campana D; Tomassetti V; Corinaldesi R Ann Oncol; 2001; 12 Suppl 2():S95-9. PubMed ID: 11762360 [TBL] [Abstract][Full Text] [Related]
34. Systemic treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETS): current approaches and future options. Strosberg JR Endocr Pract; 2014 Feb; 20(2):167-75. PubMed ID: 24014009 [TBL] [Abstract][Full Text] [Related]
35. Clinical significance of blood chromogranin A measurement in neuroendocrine tumours. Seregni E; Ferrari L; Bajetta E; Martinetti A; Bombardieri E Ann Oncol; 2001; 12 Suppl 2():S69-72. PubMed ID: 11762355 [TBL] [Abstract][Full Text] [Related]
36. New and Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors. Phan AT; Kunz PL; Reidy-Lagunes DL Clin Adv Hematol Oncol; 2015 May; 13(5 Suppl 5):1-18; quiz 1 p following 18. PubMed ID: 26430956 [TBL] [Abstract][Full Text] [Related]